Advertisement
Review Article| Volume 53, ISSUE 2, P473-492, March 2023

Download started.

Ok

Topical Ocular Therapeutics in Small Animals

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Veterinary Clinics: Small Animal Practice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Grass G.M.
        • Robinson J.R.
        Mechanisms of corneal drug penetration. I: In vivo and in vitro kinetics.
        J Pharm Sci. 1988; 77: 3-14
        • Grass G.M.
        • Robinson J.R.
        Mechanisms of corneal drug penetration. II: Ultrastructural analysis of potential pathways for drug movement.
        J Pharm Sci. 1988; 77: 15-23
        • Grass G.M.
        • Cooper E.R.
        • Robinson J.R.
        Mechanisms of corneal drug penetration III: Modeling of molecular transport.
        J Pharm Sci. 1988; 77: 24-26
        • Sasaki H.
        • Yamamura K.
        • Mukai T.
        • et al.
        Enhancement of ocular drug penetration.
        Crit Rev Ther Drug Carrier Syst. 1999; 16: 85-146
        • Prausnitz M.R.
        • Noonan J.S.
        Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye.
        J Pharm Sci. 1998; 87: 1479-1488
        • Ahmed I.
        • Patton T.F.
        Importance of the noncorneal absorption route in topical ophthalmic drug delivery.
        Invest Ophthalmol Vis Sci. 1985; 26 4: 584-587
        • Hämäläinen K.
        • Kananen K.
        • Auriola S.
        • et al.
        Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera.
        Invest Ophthalmol Vis Sci. 1997; 38: 627-634
        • Schoenwald R.D.
        • Deshpande G.S.
        • Rethwisch D.G.
        • et al.
        Penetration into the anterior chamber via the conjunctival/scleral pathway.
        J Ocul Pharmacol Ther. 1997; 13: 41-59
        • Lehr C.M.
        • Lee Y.H.
        • Lee V.H.
        Improved ocular penetration of gentamicin by mucoadhesive polymer polycarbophil in the pigmented rabbit.
        Invest Ophthalmol Vis Sci. 1994; 35: 2809-2814
        • Ambati J.
        • Canakis C.S.
        • Miller J.W.
        • et al.
        Diffusion of high molecular weight compounds through sclera.
        Invest Ophthalmol Vis Sci. 2000; 41: 1181-1185
        • Sebbag L.
        • Allbaugh R.A.
        • Wehrman R.F.
        • et al.
        Fluorophotometric assessment of tear volume and turnover rate in healthy dogs and cats.
        J Ocul Pharmacol Ther. 2019; 35: 497-502
        • Lederer C.M.
        • Harold R.E.
        Drop size of commercial glaucoma medications.
        Am J Ophthalmol. 1986; 101 6: 691-694
        • Agrahari V.
        • Mandal A.
        • Agrahari V.
        • et al.
        A comprehensive insight on ocular pharmacokinetics.
        Drug Deliv Transl Res. 2016; 6: 735-754
        • Sebbag L.
        • Kirner N.S.
        • Allbaugh R.A.
        • et al.
        Kinetics of fluorescein in tear film after eye drop instillation in beagle dogs: does size really matter?.
        Front Vet Sci. 2019; 6
        • Shell J.W.
        Pharmacokinetics of topically applied ophthalmic drugs.
        Surv Ophthalmol. 1982; 26: 207-218
        • Ali Y.
        • Lehmussaari K.
        Industrial perspective in ocular drug delivery.
        Adv Drug Deliv Rev. 2006; 58: 1258-1268
        • Frangie J.P.
        Clinical pharmacokinetics of various topical ophthalmic delivery systems.
        Clin Pharmacokinet. 1995; 29: 130-138
        • Hardberger R.
        • Hanna C.
        • Boyd C.M.
        Effects of drug vehicles on ocular contact time.
        Arch Ophthalmol. 1975; 93: 42-45
        • Sasaki H.
        • Yamamura K.
        • Nishida K.
        • et al.
        Delivery of drugs to the eye by topical application.
        Prog Retin Eye Res. 1996; 15: 583-620
        • Greaves J.
        • Wilson C.
        • Birmingham A.
        Assessment of the precorneal residence of an ophthalmic ointment in healthy subjects.
        Br J Clin Pharmacol. 1993; 35: 188-192
        • Ellis P.
        • Riegel M.
        Influence of ophthalmic ointments on the penetration of pilocarpine drops.
        J Ocul Pharmacol Ther. 1989; 5: 119-125
        • Weiner A.
        • Gilger B.
        Advancements in ocular drug delivery.
        Vet Ophthalmol. 2010; 13: 395-406
        • Kaur I.P.
        • Smitha R.
        Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery.
        Drug Dev Ind Pharm. 2002; 28: 353-369
        • Beckwith-Cohen B.
        • Elad D.
        • Bdolah-Abram T.
        • et al.
        Comparison of tear pH in dogs, horses, and cattle.
        Am J Vet Res. 2014; 75: 494-499
        • Malmberg G.J.
        • Lupo R.
        Compounding in veterinary ophthalmology.
        Vet Clin North Am Small Anim Pract. 2004; 34: 825-838
        • Davis K.
        • Townsend W.
        Tear-film osmolarity in normal cats and cats with conjunctivitis.
        Vet Ophthalmol. 2011; 14: 54-59
        • Sebbag L.
        • Park S.A.
        • Kass P.H.
        • et al.
        Assessment of tear film osmolarity using the TearLab(™) osmometer in normal dogs and dogs with keratoconjunctivitis sicca.
        Vet Ophthalmol. 2017; 20: 357-364
        • Urtti A.
        • Salminen L.
        Minimizing systemic absorption of topically administered ophthalmic drugs.
        Surv Ophthalmol. 1993; 37: 435-456
        • Paulsen F.P.
        • Foge M.
        • Thale A.B.
        • et al.
        Animal model for the absorption of lipophilic substances from tear fluid by the epithelium of the nasolacrimal ducts.
        Invest Ophthalmol Vis Sci. 2002; 43: 3137-3143
        • Glaze M.B.
        • Crawford M.A.
        • Nachreiner R.F.
        • et al.
        Ophthalmic corticosteroid therapy: systemic effects in the dog.
        J Am Vet Med Assoc. 1988; 192: 73-75
        • Greenberg S.
        • Plummer C.
        • Maisenbacher H.
        • et al.
        The effect of topical ophthalmic 1% atropine on heart rate and rhythm in normal dogs.
        Vet Ophthalmol. 2015; 18: 105-108
        • Herring I.P.
        • Jacobson J.D.
        • Pickett J.P.
        Cardiovascular effects of topical ophthalmic 10% phenylephrine in dogs.
        Vet Ophthalmol. 2004; 7: 41-46
        • Pascoe P.J.
        • Ilkiw J.E.
        • Stiles J.
        • et al.
        Arterial hypertension associated with topical ocular use of phenylephrine in dogs.
        J Am Vet Med Assoc. 1994; 205: 1562-1564
        • Plummer C.E.
        • MacKay E.O.
        • Gelatt K.N.
        Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs.
        Vet Ophthalmol. 2006; 9: 245-249
        • Smith L.N.
        • Miller P.E.
        • Felchle L.M.
        Effects of topical administration of latanoprost, timolol, or a combination of latanoprost and timolol on intraocular pressure, pupil size, and heart rate in clinically normal dogs.
        Am J Vet Res. 2010; 71: 1055-1061
        • Hsu K.
        • Pinard C.
        • Johnson R.
        • et al.
        Systemic absorption and adverse ocular and systemic effects after topical ophthalmic administration of 0.1% diclofenac to healthy cats.
        Am J Vet Res. 2015; 76: 253-265
        • Wilkie D.A.
        • Latimer C.A.
        Effects of topical administration of timolol maleate on intraocular pressure and pupil size in cats.
        Am J Vet Res. 1991; 52: 436-440
        • Wilkie D.A.
        • Latimer C.A.
        Effects of topical administration of timolol maleate on intraocular pressure and pupil size in dogs.
        Am J Vet Res. 1991; 52: 432-435
        • Tolar E.L.
        • Hendrix D.V.
        • Rohrbach B.W.
        • et al.
        Evaluation of clinical characteristics and bacterial isolates in dogs with bacterial keratitis: 97 cases (1993-2003).
        J Am Vet Med Assoc. 2006; 228: 80-85
        • LoPinto A.J.
        • Mohammed H.O.
        • Ledbetter E.C.
        Prevalence and risk factors for isolation of methicillin-resistant Staphylococcus in dogs with keratitis.
        Vet Ophthalmol. 2015; 18: 297-303
        • Clode A.
        • Scott E.
        Antibacterial agents, antifungal agents and antiviral agents.
        in: Gelatt J.K. Vet ophthalmol. 6th edition. John Wiley & Sons, Inc., Hoboken, NJ2021: 385-416
        • Hume-Smith K.
        • Groth A.
        • Rishniw M.
        • et al.
        Anaphylactic events observed within 4 h of ocular application of an antibiotic-containing ophthalmic preparation: 61 cats (1993-2010).
        J Feline Med Surg. 2011; 13: 744-751
        • Rowley R.A.
        • Rubin L.F.
        Aqueous humor penetration of several antibiotics in the dog.
        Am J Vet Res. 1970; 31: 43-49
        • Wang L.
        • Pan Q.
        • Zhang L.
        • et al.
        Investigation of bacterial microorganisms in the conjunctival sac of clinically normal dogs and dogs with ulcerative keratitis in Beijing, China.
        Vet Ophthalmol. 2008; 11: 145-149
        • McDonald P.J.
        • Watson D.J.
        Microbial flora of normal canine conjunctivae.
        J Small Anim Pract. 1976; 17: 809-812
        • Prado M.R.
        • Rocha M.F.
        • Brito E.H.
        • et al.
        Survey of bacterial microorganisms in the conjunctival sac of clinically normal dogs and dogs with ulcerative keratitis in Fortaleza, Ceará, Brazil.
        Vet Ophthalmol. 2005; 8: 33-37
        • Urban M.
        • Wyman M.
        • Rheins M.
        • et al.
        Conjunctival flora of clinically normal dogs.
        J Am Vet Med Assoc. 1972; 161: 201-206
        • Insler M.S.
        • Helm C.J.
        • George W.J.
        Topical vs systemic gentamicin penetration into the human cornea and aqueous humor.
        Arch Ophthalmol. 1987; 105: 922-924
        • Rootman D.S.
        • Willoughby R.P.
        • Bindlish R.
        • et al.
        Continuous flow contact lens delivery of gentamicin to rabbit cornea and aqueous humor.
        J Ocul Pharmacol. 1992; 8: 317-323
        • Hendrix D.V.
        • Ward D.A.
        • Barnhill M.A.
        Effects of antibiotics on morphologic characteristics and migration of canine corneal epithelial cells in tissue culture.
        Am J Vet Res. 2001; 62: 1664-1669
        • Nelson J.D.
        • Silverman V.
        • Lima P.H.
        • et al.
        Corneal epithelial wound healing: a tissue culture assay on the effect of antibiotics.
        Curr Eye Res. 1990; 9: 277-285
        • Stern G.A.
        • Schemmer G.B.
        • Farber R.D.
        • et al.
        Effect of topical antibiotic solutions on corneal epithelial wound healing.
        Arch Ophthalmol. 1983; 101: 644-647
        • Wang A.L.
        • Ledbetter E.C.
        • Kern T.J.
        Orbital abscess bacterial isolates and in vitro antimicrobial susceptibility patterns in dogs and cats.
        Vet Ophthalmol. 2009; 12: 91-96
        • Stewart W.C.
        • Crean C.S.
        • Zink R.C.
        • et al.
        Pharmacokinetics of azithromycin and moxifloxacin in human conjunctiva and aqueous humor during and after the approved dosing regimens.
        Am J Ophthalmol. 2010; 150: 744-751.e2
        • Kuehne J.J.
        • Yu A.L.
        • Holland G.N.
        • et al.
        Corneal pharmacokinetics of topically applied azithromycin and clarithromycin.
        Am J Ophthalmol. 2004; 138: 547-553
        • Breitschwerdt E.B.
        • Papich M.G.
        • Hegarty B.C.
        • et al.
        Efficacy of doxycycline, azithromycin, or trovafloxacin for treatment of experimental Rocky Mountain spotted fever in dogs.
        Antimicrobial Agents Chemother. 1999; 43: 813-821
        • Biswas S.
        • Maggi R.G.
        • Papich M.G.
        • et al.
        Comparative activity of pradofloxacin, enrofloxacin, and azithromycin against Bartonella henselae isolates collected from cats and a human.
        J Clin Microbiol. 2010; 48: 617-618
        • Biswas S.
        • Maggi R.G.
        • Papich M.G.
        • et al.
        Molecular mechanisms of Bartonella henselae resistance to azithromycin, pradofloxacin and enrofloxacin.
        J Antimicrob Chemother. 2009; 65: 581-582
        • Yue J.
        • Lyu J.X.
        • Si W.
        • et al.
        Comparison study on sensitivity of five ophthalmic antibiotics to common drug-resistant Staphylococci on ocular surface.
        Chi J Ophthalmol. 2020; 56: 621-625
        • Blondeau J.M.
        Fluoroquinolones: mechanism of action, classification, and development of resistance.
        Surv Ophthalmol. 2004; 49: S73-S78
        • Ledbetter E.C.
        • Hendricks L.M.
        • Riis R.C.
        • et al.
        In vitro fluoroquinolone susceptibility of Pseudomonas aeruginosa isolates from dogs with ulcerative keratitis.
        Am J Vet Res. 2007; 68: 638-642
        • Yu-Speight A.W.
        • Kern T.J.
        • Erb H.N.
        Ciprofloxacin and Ofloxacin Aqueous Humor Concentrations After Topical Administration in Dogs Undergoing Cataract Surgery.
        Invest Ophthalmol Vis Sci. 2003; 44: 1452
        • Schlech B.A.
        • Alfonso E.
        Overview of the potency of moxifloxacin ophthalmic solution 0.5% (VIGAMOX).
        Surv Ophthalmol. 2005; 50: S7-S15
        • Deschênes J.
        • Blondeau J.
        Besifloxacin in the management of bacterial infections of the ocular surface.
        Can J Ophthalmol. 2015; 50: 184-191
        • Park Y.W.
        • Kang B.J.
        • Lim J.H.
        • et al.
        Corneal plaque containing levofloxacin in a dog.
        Vet Ophthalmol. 2015; 18: 521-526
        • Seitz B.
        • Hayashi S.
        • Wee W.R.
        • et al.
        In vitro effects of aminoglycosides and fluoroquinolones on keratocytes.
        Invest Ophthalmol Vis Sci. 1996; 37: 656-665
        • Maboni G.
        • Gressler L.T.
        • Espindola J.P.
        • et al.
        Differences in the antimicrobial susceptibility profiles of Moraxella bovis, M. bovoculi and M. ovis.
        Braz J Microbiol. 2015; 46: 545-549
        • Griffin M.O.
        • Fricovsky E.
        • Ceballos G.
        • et al.
        Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature.
        Am J Physiol Cell Physiol. 2010; 299: C539-C548
        • Chandler H.L.
        • Gemensky-Metzler A.J.
        • Bras I.D.
        • et al.
        In vivo effects of adjunctive tetracycline treatment on refractory corneal ulcers in dogs.
        J Am Vet Med Assoc. 2010; 237: 378-386
        • De Clercq E.
        Antiviral drugs in current clinical use.
        J Clin Virol. 2004; 30: 115-133
        • Maggs D.J.
        • Clarke H.E.
        In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1.
        Am J Vet Res. 2004; 65: 399-403
        • Nasisse M.P.
        • Guy J.S.
        • Davidson M.G.
        • et al.
        In vitro susceptibility of feline herpesvirus-1 to vidarabine, idoxuridine, trifluridine, acyclovir, or bromovinyldeoxyuridine.
        Am J Vet Res. 1989; 50: 158-160
        • Gould D.
        Feline herpesvirus-1: ocular manifestations, diagnosis and treatment options.
        J Feline Med Surg. 2011; 13: 333-346
        • Maggs D.J.
        Antiviral therapy for feline herpesvirus infections.
        Vet Clin North Am Small Anim Pract. 2010; 40: 1055-1062
        • Spertus C.B.
        • Mohammed H.O.
        • Ledbetter E.C.
        Effects of topical ocular application of 1% trifluridine ophthalmic solution in dogs with experimentally induced recurrent ocular canine herpesvirus-1 infection.
        Am J Vet Res. 2016; 77: 1140-1147
        • O’Brien T.P.
        Therapy of ocular fungal infections.
        Ophthalmol Clin North Am. 1999; 12: 33-50
        • Mathes R.L.
        • Reber A.J.
        • Hurley D.J.
        • et al.
        Effects of antifungal drugs and delivery vehicles on morphology and proliferation of equine corneal keratocytes in vitro.
        Am J Vet Res. 2010; 71: 953-959
        • McGhee C.N.
        Pharmacokinetics of ophthalmic corticosteroids.
        Br J Ophthalmol. 1992; 76: 681-684
        • Musson D.G.
        • Bidgood A.M.
        • Olejnik O.
        An in vitro comparison of the permeability of prednisolone, prednisolone sodium phosphate, and prednisolone acetate across the NZW rabbit cornea.
        J Ocul Pharmacol. 1992; 8: 139-150
        • Leibowitz H.M.
        • Kupferman A.
        Antiinflammatory medications.
        Int Ophthalmol Clin. 1980; 20: 117-134
        • Dannenberg Jr., A.M.
        The antinflammatory effects of glucocorticosteroids. A brief review of the literature.
        Inflamm Res. 1979; 3: 329-343
        • Phillips K.
        • Arffa R.
        • Cintron C.
        • et al.
        Effects of prednisolone and medroxyprogesterone on corneal wound healing, ulceration, and neovascularization.
        Arch Ophthalmol. 1983; 101: 640-643
        • Boneham G.C.
        • Collin H.B.
        Steroid inhibition of limbal blood and lymphatic vascular cell growth.
        Curr Eye Res. 1995; 14: 1-10
        • Brown S.I.
        • Weller C.A.
        • Vidrich A.M.
        Effect of corticosteroids on corneal collagenase of rabbits.
        Am J Ophthalmol. 1970; 70: 744-747
        • Zhan G.-L.
        • Miranda O.C.
        • Bito L.Z.
        Steroid glaucoma: Corticosteroid-induced ocular hypertension in cats.
        Exp Eye Res. 1992; 54: 211-218
        • Gelatt K.N.
        • Mackay E.O.
        The ocular hypertensive effects of topical 0.1% dexamethasone in beagles with inherited glaucoma.
        J Ocul Pharmacol Ther. 1998; 14: 57-66
        • Gosling A.A.
        • Kiland J.A.
        • Rutkowski L.E.
        • et al.
        Effects of topical corticosteroid administration on intraocular pressure in normal and glaucomatous cats.
        Vet Ophthalmol. 2016; 19: 69-76
        • Eichenbaum J.
        • Macy D.
        • Severin G.
        • et al.
        Effect in large dogs of ophthalmic prednisolone acetate on adrenal gland and hepatic function.
        J Am Anim Hosp Assoc. 1988; 24: 705-709
        • Rankin A.J.
        • KuKanich K.S.
        • Schermerhorn T.
        • et al.
        Evaluation of diabetes mellitus regulation in dogs treated with ophthalmic preparations of prednisolone acetate versus diclofenac sodium.
        Am J Vet Res. 2019; 80: 1129-1135
        • Dziezyc JM N.
        • Smith W.
        Effect of flurbiprofen and corticosteroids on the ocular irritative response in dogs.
        Vet Comp Ophthalmol. 1995; 5: 42-45
        • Ward D.A.
        Comparative efficacy of topically applied flurbiprofen, diclofenac, tolmetin, and suprofen for the treatment of experimentally induced blood-aqueous barrier disruption in dogs.
        Am J Vet Res. 1996; 57: 875-878
        • Rankin A.J.
        • Khrone S.G.
        • Stiles J.
        Evaluation of four drugs for inhibition of paracentesis-induced blood-aqueous humor barrier breakdown in cats.
        Am J Vet Res. 2011; 72: 826-832
        • Palmero M.
        • Bellot J.L.
        • Alcoriza N.
        • et al.
        The ocular pharmacokinetics of topical diclofenac is affected by ocular inflammation.
        Ophthalmic Res. 1999; 31: 309-316
        • Trousdale M.D.
        • Dunkel E.C.
        • Nesburn A.B.
        Effect of flurbiprofen on herpes simplex keratitis in rabbits.
        Invest Ophthalmol Vis Sci. 1980; 19: 267-270
        • Rao N.A.
        • Patchett R.
        • Fernandez M.A.
        • et al.
        Treatment of experimental granulomatous uveitis by lipoxygenase and cyclo-oxygenase inhibitors.
        Arch Ophthalmol. 1987; 105: 413-415
        • Hendrix D.V.H.
        • Ward D.A.
        • Barnhill M.A.
        Effects of anti-inflammatory drugs and preservatives on morphologic characteristics and migration of canine corneal epithelial cells in tissue culture.
        Vet Ophthalmol. 2002; 5: 127-135
        • Hersh P.
        • Rice B.
        • Baer J.
        • et al.
        Topical nonsteroidal agents and corneal wound healing.
        Arch Ophthalmol. 1990; 108: 577-583
        • Flach A.J.
        Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs.
        Trans Am Ophthalmol Soc. 2001; 99: 205-210
        • Guidera A.C.
        • Luchs J.I.
        • Udell I.J.
        Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs.
        Ophthalmology. 2001; 108: 936-944
        • Lin J.C.
        • Rapuano C.J.
        • Laibson P.R.
        • et al.
        Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery.
        Arch Ophthalmol. 2000; 118: 1129-1132
        • Krohne S.G.
        • Gionfriddo J.
        • Morrison E.A.
        Inhibition of pilocarpine-induced aqueous humor flare, hypotony, and miosis by topical administration of anti-inflammatory and anesthetic drugs to dogs.
        Am J Vet Res. 1998; 59: 482-488
        • Millichamp N.J.
        • Dziezyc J.
        • Olsen J.W.
        Effect of flurbiprofen on facility of aqueous outflow in the eyes of dogs.
        Am J Vet Res. 1991; 52: 1448-1451
        • Lu J.
        • English R.
        • Nadelstein B.
        • et al.
        Comparison of topically applied flurbiprofen or bromfenac ophthalmic solution on post-operative ocular hypertension in canine patients following cataract surgery.
        Vet Ophthalmol. 2017; 20: 107-113
        • Pirie C.G.
        • Maranda L.S.
        • Pizzirani S.
        Effect of topical 0.03% flurbiprofen and 0.005% latanoprost, alone and in combination, on normal canine eyes.
        Vet Ophthalmol. 2011; 14: 71-79
        • Lanuza R.
        • Rankin A.J.
        • KuKanich B.
        • et al.
        Evaluation of systemic absorption and renal effects of topical ophthalmic flurbiprofen and diclofenac in healthy cats.
        Vet Ophthalmol. 2016; 19: 24-29
        • Cawrse M.A.
        • Ward D.A.
        • Hendrix D.V.
        Effects of topical application of a 2% solution of dorzolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs.
        Am J Vet Res. 2001; 62: 859-863
      1. Kennard G, Whelan NC. The additive effect of dorzolamide and latanoprost in reducing intraocular pressure in normal dogs. Abstract presented at: 32nd Annual Meeting of the American College of Veterinary Ophthalmologists; October 10–13 2001; Sarasota, FL.

      2. Whelan NC, Welch P, Pace A. A comparison of the efficacy of topical brinzolamide and dorzolamide alone and in combination with oral methazolamide in decreasing normal canine intraocular pressure. Abstract presented at: 30th Annual Meeting of the American College of Veterinary Ophthalmologists; Nov 3–7 1997; Chicago, IL.

        • Rainbow M.E.
        • Dziezyc J.
        Effects of twice daily application of 2% dorzolamide on intraocular pressure in normal cats.
        Vet Ophthalmol. 2003; 6: 147-150
        • Rankin A.J.
        • Crumley W.R.
        • Allbaugh R.A.
        Effects of ocular administration of ophthalmic 2% dorzolamide hydrochloride solution on aqueous humor flow rate and intraocular pressure in clinically normal cats.
        Am J Vet Res. 2012; 73: 1074-1078
        • Sigle K.J.
        • Camaño-Garcia G.
        • Carriquiry A.L.
        • et al.
        The effect of dorzolamide 2% on circadian intraocular pressure in cats with primary congenital glaucoma.
        Vet Ophthalmol. 2011; 14: 48-53
        • Gray H.E.
        • Willis A.M.
        • Morgan R.V.
        Effects of topical administration of 1% brinzolamide on normal cat eyes.
        Vet Ophthalmol. 2003; 6: 285-290
        • McLellan G.J.
        • Lin T.-L.
        • Hildreth S.
        • et al.
        Diurnal intraocular pressure and response to topically administered 1% brinzolamide in a spontaneous feline model of primary congenital glaucoma.
        Invest Ophthalmol Vis Sci. 2009; 50: 4059
        • Thiessen C.E.
        • Tofflemire K.L.
        • Makielski K.M.
        • et al.
        Hypokalemia and suspected renal tubular acidosis associated with topical carbonic anhydrase inhibitor therapy in a cat.
        J Vet Emerg Crit Care (San Antonio). 2016; 26: 870-874
        • Beckwith-Cohen B.
        • Bentley E.
        • Gasper D.J.
        • et al.
        Keratitis in six dogs after topical treatment with carbonic anhydrase inhibitors for glaucoma.
        J Am Vet Med Assoc. 2015; 247: 1419-1426
        • Willis A.M.
        • Diehl K.A.
        • Robbin T.E.
        Advances in topical glaucoma therapy.
        Vet Ophthalmol. 2002; 5: 9-17
        • Gelatt K.N.
        • Larocca R.D.
        • Gelatt J.K.
        • et al.
        Evaluation of multiple doses of 4 and 6% timolol, and timolol combined with 2% pilocarpine in clinically normal beagles and beagles with glaucoma.
        Am J Vet Res. 1995; 56: 1325-1331
        • Gum G.
        • Larocca R.
        • Gelatt K.
        The effect of topical timolol maleate on intraocular pressure in normal beagles and beagles with inherited glaucoma.
        Prog Vet Comp Ophthalmol. 1991; 1: 141-150
        • Willis A.M.
        Ocular hypotensive drugs.
        Vet Clin North Am Small Anim Pract. 2004; 34: 755-776
        • McLellan G.J.
        • Miller P.E.
        Feline glaucoma--a comprehensive review.
        Vet Ophthalmol. 2011; 14: 15-29
        • Studer M.E.
        • Martin C.L.
        • Stiles J.
        Effects of 0.005% latanoprost solution on intraocular pressure in healthy dogs and cats.
        Am J Vet Res. 2000; 61: 1220-1224
        • Gelatt K.N.
        • MacKay E.O.
        Effect of different dose schedules of latanoprost on intraocular pressure and pupil size in the glaucomatous Beagle.
        Vet Ophthalmol. 2001; 4: 283-288
        • Gelatt K.N.
        • MacKay E.O.
        Effect of different dose schedules of travoprost on intraocular pressure and pupil size in the glaucomatous Beagle.
        Vet Ophthalmol. 2004; 7: 53-57
        • Mackay E.O.
        • McLaughlin M.
        • Plummer C.E.
        • et al.
        Dose response for travoprost® in the glaucomatous beagle.
        Vet Ophthalmol. 2012; 15: 31-35
        • Gelatt K.N.
        • Mackay E.O.
        Effect of different dose schedules of bimatoprost on intraocular pressure and pupil size in the glaucomatous Beagle.
        J Ocul Pharmacol Ther. 2002; 18: 525-534
        • Tofflemire K.L.
        • Whitley E.M.
        • Allbaugh R.A.
        • et al.
        Comparison of two- and three-times-daily topical ophthalmic application of 0.005% latanoprost solution in clinically normal dogs.
        Am J Vet Res. 2015; 76: 625-631
        • Plummer C.
        Medical therapy for glaucoma.
        in: Gelatt J.K. Vet Ophthalmol. 6th edition. John Wiley & Sons, Inc., Hoboken, NJ2021: 451-478
        • Kahane N.
        • Bdolah-Abram T.
        • Raskansky H.
        • et al.
        The effects of 1% prednisolone acetate on pupil diameter and intraocular pressure in healthy dogs treated with 0.005% latanoprost.
        Vet Ophthalmol. 2016; 19: 473-479
        • Bartoe J.T.
        • Davidson H.J.
        • Horton M.T.
        • et al.
        The effects of bimatoprost and unoprostone isopropyl on the intraocular pressure of normal cats.
        Vet Ophthalmol. 2005; 8: 247-252
        • Regnier A.
        • Lemagne C.
        • Ponchet A.
        • et al.
        Ocular effects of topical 0.03% bimatoprost solution in normotensive feline eyes.
        Vet Ophthalmol. 2006; 9: 39-43
        • Bhattacherjee P.
        • Williams B.S.
        • Paterson C.A.
        Responses of intraocular pressure and the pupil of feline eyes to prostaglandin EP1 and FP receptor agonists.
        Invest Ophthalmol Vis Sci. 1999; 40: 3047-3053
        • McDonald J.E.
        • Kiland J.A.
        • Kaufman P.L.
        • et al.
        Effect of topical latanoprost 0.005% on intraocular pressure and pupil diameter in normal and glaucomatous cats.
        Vet Ophthalmol. 2016; 19: 13-23
        • Fischer G.
        • Wittmann-Liebold B.
        • Lang K.
        • et al.
        Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins.
        Nature (London). 1989; 337: 476-478
        • Handschumacher R.E.
        • Harding M.W.
        • Rice J.
        • et al.
        Cyclophilin: a specific cytosolic binding protein for cyclosporin A.
        Science (New York, NY). 1984; 226: 544-547
        • Morgan R.V.
        • Abrams K.L.
        Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs.
        J Am Vet Med Assoc. 1991; 199: 1043-1046
        • Kaswan R.L.
        • Salisbury M.-A.
        • Ward D.A.
        Spontaneous canine keratoconjunctivitis sicca: a useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops.
        Arch Ophthalmol. 1989; 107: 1210-1216
        • Rankin A.J.
        Anti-inflammatory and immunosuppressant drugs.
        in: Gelatt J.K. Vet ophthalmol. 6th edition. John Wiley & Sons, Inc., 2021: 417-434 (chap 8.3)
      3. Adkins E.A., An Investigation of the Safety and Efficacy Of Topical Ophthalmic Application Of Tacrolimus In Dogs. proceedings of 34th Annual Meeting of the American College of Veterinary Ophthalmologists: Coeur D’Alene, ID, 2003.

        • Hendrix D.V.H.
        • Adkins E.A.
        • Ward D.A.
        • et al.
        An Investigation Comparing the Efficacy of Topical Ocular Application of Tacrolimus and Cyclosporine in Dogs.
        Vet Med Int. 2011; 2011: 487592-487595
        • John C.
        • Gopinathan A.
        • Singh K.
        • et al.
        Clinical evaluation of topical tacrolimus ointment usage in different stages of keratoconjunctivitis sicca in dogs.
        Turkish J Vet Anim Sci. 2018; 42: 259-268
        • Berdoulay A.
        • English R.V.
        • Nadelstein B.
        Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca.
        Vet Ophthalmol. 2005; 8: 225-232
        • Radziejewski K.
        • Balicki I.
        Comparative clinical evaluation of tacrolimus and cyclosporine eye drops for the treatment of canine keratoconjunctivitis sicca.
        Acta veterinaria Hungarica (Budapest 1983). 2016; 64: 313-329
        • Spiess A.K.
        • Sapienza J.S.
        • Mayordomo A.
        Treatment of proliferative feline eosinophilic keratitis with topical 1.5% cyclosporine: 35 cases.
        Vet Ophthalmol. 2009; 12: 132-137
        • Gelatt K.N.
        • Boggess T.S.
        • Cure T.H.
        Evaluation of mydriatics in the cat.
        Anim Hosp. 1973; 9: 283-287
        • Lynch R.
        • Rubin L.F.
        Salivation induced in dogs by conjunctival instillation of atropine.
        J Am Vet Med Assoc. 1965; 147: 511-513
        • Rubin L.F.
        • Wolfes R.L.
        Mydriatics for canine ophthalmoscopy.
        J Am Vet Med Assoc. 1962; 140: 137-141
        • Hollingsworth S.R.
        • Canton D.D.
        • Buyukmihci N.C.
        • et al.
        Effect of topically administered atropine on tear production in dogs.
        J Am Vet Med Assoc. 1992; 200: 1481-1484
        • Margadant D.L.
        • Kirkby K.
        • Andrew S.E.
        • et al.
        Effect of topical tropicamide on tear production as measured by Schirmer's tear test in normal dogs and cats.
        Vet Ophthalmol. 2003; 6: 315-320
        • Stadtbäumer K.
        • Frommlet F.
        • Nell B.
        Effects of mydriatics on intraocular pressure and pupil size in the normal feline eye.
        Vet Ophthalmol. 2006; 9: 233-237
        • Stadtbäumer K.
        • Köstlin R.G.
        • Zahn K.J.
        Effects of topical 0.5% tropicamide on intraocular pressure in normal cats.
        Vet Ophthalmol. 2002; 5: 107-112
        • Kovalcuka L.
        • Ilgazs A.
        • Bandere D.
        • et al.
        Changes in intraocular pressure and horizontal pupil diameter during use of topical mydriatics in the canine eye.
        Open Vet J. 2017; 7: 16-22
        • Wallin-Håkanson N.
        • Wallin-Håkanson B.
        The effects of topical tropicamide and systemic medetomidine, followed by atipamezole reversal, on pupil size and intraocular pressure in normal dogs.
        Vet Ophthalmol. 2001; 4: 3-6
        • Taylor N.R.
        • Zele A.J.
        • Vingrys A.J.
        • et al.
        Variation in intraocular pressure following application of tropicamide in three different dog breeds.
        Vet Ophthalmol. 2007; 10: 8-11
        • Herring I.P.
        Mydriatics/cycloplegics, anesthetics, and tear substitutes and stimulators.
        in: Gelatt J.K. Vet Ophthalmol. 6th edition. John Wiley and Sons, Inc., Hoboken, NJ2021: 435-450
        • Egashira S.M.
        • Kish L.L.
        • Twelker J.D.
        • et al.
        Comparison of cyclopentolate versus tropicamide cycloplegia in children.
        Optom Vis Sci. 1993; 70: 1019-1026
        • Gettes B.C.
        • Belmont O.
        Tropicamide: comparative cycloplegic effects.
        Arch Ophthalmol. 1961; 66: 336-340
        • Hiatt R.L.
        • Jerkins G.
        Comparison of atropine and tropicamide in esotropia.
        Ann Ophthalmol. 1983; 15: 341-343
        • Lovasik J.V.
        Pharmacokinetics of topically applied cyclopentolate HCl and tropicamide.
        Am J Optom Physiol Opt. 1986; 63: 787-803
        • Gomes F.E.
        • Bentley E.
        • Lin T.L.
        • et al.
        Effects of unilateral topical administration of 0.5% tropicamide on anterior segment morphology and intraocular pressure in normal cats and cats with primary congenital glaucoma.
        Vet Ophthalmol. 2011; 14: 75-83
        • Salazar M.
        • Patil P.N.
        An explanation for the long duration of mydriatic effect of atropine in eye.
        Invest Ophthalmol. 1976; 15: 671-673
        • Salazar M.
        • Shimada K.
        • Patil P.N.
        Iris pigmentation and atropine mydriasis.
        J Pharmacol Exp Ther. 1976; 197: 79-88
        • Ward D.A.
        Clinical pharacology and therapeutics. Part 3.
        in: Gelatt J.K. Vet ophthalmol. 3rd edition. Lippincott Williams and Wilkins, Philadelphia, PA1999: 336-354
        • Costa D.
        • Leiva M.
        • Coyo N.
        • et al.
        Effect of topical 1% cyclopentolate hydrochloride on tear production, pupil size, and intraocular pressure in healthy Beagles.
        Vet Ophthalmol. 2016; 19: 449-453